Adrenal disease

Evaluating the impact of adrenalectomy and mineralocorticoid receptor antagonists for primary aldosteronism on left ventricular remodeling: a systematic review and meta-analysis

Eur J EndocrinolPublished Systematic review and meta-analysis

Pooled result · Reduction in LVMIResult — go to the resultDifference-in-differences SMD −0.15 95% CI −0.26 to −0.03

Authors' conclusion

This meta-analysis suggests that both adrenalectomy and MRAs improve LV remodeling. Although adrenalectomy was generally associated with slightly greater LVMI reductions than MRAs, the impact of optimized MRA therapy on LVMI reduction remains uncertain. When focusing specifically on patients with unilateral PA, adrenalectomy was associated with more pronounced regression of LV remodeling compared with MRA therapy.

Study context

Population
Patients with primary aldosteronism (PA)
Participants
1,197 patients10 studies
Comparison
Adrenalectomy vs mineralocorticoid receptor antagonists (MRAs)
Outcome
Reduction in left ventricular (LV) mass index (LVMI) after treatment

Pooled result

Reduction in LVMI

Difference-in-differences SMD

−0.15

95% CI −0.26 to −0.03

By group

Adrenalectomy

−0.49

95% CI −0.65 to −0.33

SMD

MRAs

−0.35

95% CI −0.48 to −0.22

SMD

Adrenalectomyvs MRAs
difference-in-differences SMD −0.15 (95% CI −0.26 to −0.03)

As reported in the abstract

Further pooled results

LV mass index (LVMI) reduction in unilateral PA studies

Adrenalectomy demonstrated greater LVMI reduction than MRAs

Original publication

Evaluating the impact of adrenalectomy and mineralocorticoid receptor antagonists for primary aldosteronism on left ventricular remodeling: a systematic review and meta-analysis. Eur J Endocrinol. Published 6 January 2026. doi:10.1093/ejendo/lvaf271

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.